Treatment consistency across levels of baseline renal function with Rivaroxaban or Warfarin: A ROCKET AF (Rivaroxaban once-daily, oral, direct factor Xa inhibition compared with vi...

Saved in:

Published in:	Circulation 135(2017), 10, Seite 1001-1003
Authors and Corporations:	Lindner, Samuel M. (Author), Hacke, Werner (Author)
Title:	Treatment consistency across levels of baseline renal function with Rivaroxaban or Warfarin: A ROCKET AF (Rivaroxaban once-daily, oral, direct factor Xa inhibition compared with vitamin k antagonism for prevention of stroke and embolism trial in atrial fibrillation) analysis/ Samuel M. Lindner, Christopher B. Fordyce, Anne S. Hellkamp, Yuliya Lokhnygina, Jonathan P. Piccini, Günter Breithardt, Kenneth W. Mahaffey, Daniel E. Singer, Werner Hacke, Jonathan L. Halperin, Graeme J. Hankey, Scott D. Berkowitz, Christopher C. Nessel, Richard C. Becker, Keith A.A. Fox, Manesh R. Patel and on behalf of the ROCKET AF Steering Committee and Investigators
Type of Resource:	E-Book Component Part
Language:	English
published:	March 6, 2017
Series:	: Circulation, 135(2017), 10, Seite 1001-1003 , volume:135
Source:	Verbunddaten SWB Lizenzfreie Online-Ressourcen